|
|
Drugs for Dependent Personality Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 58)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Sertraline | approved | Phase 4 | 282 | 79617-96-2 | 68617 | (+)-Sertraline (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (1S,4S)-Sertraline (1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine (1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 79559-97-0 (Hydrochloride) 79617-96-2 AB00514002 AB1004870 AC-15639 AC1L2A41 AC1Q3O5N AC1Q3XJU Apo-Sertraline BIDD:GT0768 BIDD:PXR0193 BPBio1_001285 BRD-K82036761-003-02-1 BRN 5753709 BSPBio_001167 BSPBio_002698 C07246 C17H17Cl2N CHEBI:9123 CHEMBL809 CID68617 CP 51974 Cp 51974 D02360 DB01104 DB08567 FT-0081122 HSDB 7037 KBio3_001918 | KBioGR_001724 LS-94179 Lustral MLS001195647 MLS002222308 MolPort-002-885-860 NCGC00092386-03 NCGC00092386-04 NCGC00092386-05 NCGC00092386-06 NCGC00092386-07 NCGC00092386-08 NCGC00092386-09 Prestwick3_001014 SMR000596516 SPBio_000385 SRE Sertralina Sertralina [Spanish] Sertraline Sertraline (INN) Sertraline Hydrochloride Sertraline [INN:BAN] Sertraline [Zoloft] Sertraline hydrochloride Sertralinum Sertralinum [Latin] Spectrum2_000493 Spectrum3_001079 Spectrum4_001232 Sultamicillin Tosylate UNII-QUC7NX6WMB Zoloft cis-(+)-Sertraline sertraline sertraline (Zoloft) |
| | 2 | | Paroxetine | approved, investigational | Phase 4 | 221 | 61869-08-7 | 43815 | (-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine (-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine (-)-Paroxetine (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine (-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine (3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine (3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine (3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine 110429-35-1 3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride 61869-08-7 63952-24-9 64006-44-6 (maleate) 78246-49-8 (hydrochloride) AB00514724 AC1L2AKL AC1Q1H18 AC1Q4LV6 Aropax BIDD:GT0673 BPBio1_000949 BRD-K37991163-003-02-7 BRL 29060 BRL-29060 BSPBio_000861 Brisdelle C07415 C19H20FNO3 CHEBI:7936 CHEMBL490 CID43815 Casbol D02362 DB00715 DivK1c_006884 FG 7051 FG-7051 FT-0085087 Frosinor | HMS2090H05 I14-7752 KBio1_001828 KBio2_002232 KBio2_004800 KBio2_007368 KBioSS_002232 LS-114249 MolPort-003-849-791 Motivan NCGC00025355-02 NCGC00025355-03 NCGC00025355-04 NCGC00025355-05 NCGC00025355-06 NCGC00025355-07 NCGC00025355-08 NNC-20-7051 Paroxetina Paroxetina [INN-Spanish] Paroxetine Paroxetine (TN) Paroxetine (USP/INN) Paroxetine Hcl Paroxetine Hydrochloride Paroxetine Mesylate Paroxetine [USAN:INN:BAN] Paroxetinum Paroxetinum [INN-Latin] PaxPar Paxetil Paxil Paxil CR Pexeva Prestwick3_000851 Seroxat Seroxat CR SpecPlus_000788 Spectrum5_001665 Spectrum_001752 TL8003967 UNII-41VRH5220H [3H]Paroxetine paroxetine |
| | 3 | | Fluoxetine | approved | Phase 4 | 229 | 54910-89-3 | 3386 | (+) or (-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine (+) or (-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine (+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine (+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine (+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine (+/-)-Fluoxetine (+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine (+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine (+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine (+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine] (+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine 3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine 52341-67-0 54910-89-3 57226-07-0 59333-67-4 (hydrochloride) AB00053774 AC-14564 AC1L1FTH AKOS003663021 Adofen Animex-On BPBio1_000354 BPBio1_000509 BRD-A31159102-001-01-9 BRD-A31159102-003-05-6 BSPBio_000461 BSPBio_003375 Bio-0787 Biomol-NT_000152 C17H18F3NO CHEBI:5118 CHEMBL41 CID3386 D00326 DB00472 Deprex DivK1c_006819 Eufor Floxetine Fluctin Fluoxeren Fluoxetin Fluoxetina Fluoxetina [INN-Spanish] Fluoxetina [Spanish] Fluoxetine Fluoxetine (TN) Fluoxetine (USAN/INN) Fluoxetine Hcl Fluoxetine Hydrochloride Fluoxetine [USAN:INN:BAN] Fluoxetinum | Fluoxetinum [INN-Latin] Fluoxétine Fluval Fontex Foxetin HMS2090H14 KBio1_001763 KBio2_002159 KBio2_004727 KBio2_007295 KBio3_002595 KBioGR_001166 KBioSS_002159 L000931 LS-31040 Lilly-110140 Lopac0_000558 Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine MolPort-001-683-482 N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine NCGC00015428-10 NCGC00024879-03 NCGC00024879-04 NSC283480 Portal Prestwick0_000511 Prestwick1_000511 Prestwick2_000511 Prestwick3_000511 Prozac Prozac Weekly Pulvules Reconcile Reneuron SPBio_001815 SPBio_002382 STK734483 Sarafem SpecPlus_000723 Spectrum2_001658 Spectrum3_001648 Spectrum4_000613 Spectrum5_001518 Spectrum_001679 TL8003595 UNII-01K63SUP8D dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine fluoxetine fluoxetine (Prozac) nchembio.534-comp2 | |
| | 4 | | Citalopram | approved | Phase 4 | 494 | 59729-33-8 | 2771 | 1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile 1,3-dihydro[3,4]benzofuran-5-carbonitrile 1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile 59729-33-8 AB00513896 AC-12214 AC1L1EFH AE-641/00603021 Akarin BPBio1_000929 BRD-A47598013-004-02-0 BSPBio_000843 Bonitrile C07572 C20H21FN2O CHEBI:3723 CHEMBL549 CID2771 CPD000465669 Celapram Celexa Celius Ciazil Cilift Cipram Cipramil Ciprapine Citabax Citadur Citadur (TN) Citalec Citalopram Citalopram (USP/INN) Citalopram Hydrobromide Citalopram [Celexa] Citalopram [INN:BAN] Citalopram hydrobromide Citalopramum Citalopramum [INN-Latin] | Citol Citopam Citox Citrol Cytalopram D07704 DB00215 Dalsan EINECS 261-891-1 Elopram HMS2090O09 HMS2093A14 Humorup I01-0382 InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3 L001223 LS-84327 Lopac0_000258 Lu 10-171 Lu-10-171 MolPort-003-666-794 NCGC00015267-07 NCGC00025160-02 Nitalapram Oropram Perrigo Citalopram Pramcit Prestwick3_000692 Recital SAM002589960 ST069372 STL058639 Seropram Talam Talohexal Temperax UNII-0DHU5B8D6V Vodelax Zentius Zetalo [3H]Citalopram citalopram | |
| | 5 | | Naltrexone | approved, investigational | Phase 4 | 349 | 16590-41-3 | 5360515 | 16590-41-3 16676-29-2 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one 17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one 3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one BIDD:GT0405 BPBio1_000146 BRD-K88172511-310-03-8 BRN 3596648 BSPBio_000132 C07253 CCRIS 3506 CHEBI:121459 CHEBI:7465 CHEMBL142 CID5360515 Celupan D05113 DB00704 Depade EINECS 240-649-9 EN-1639A HMS2089O11 HS-0002 HSDB 6750 LS-92094 MLS002153483 MolPort-004-920-221 MorViva | N-Cyclopropylmethyl-14-hydroxydihydromorphinone N-Cyclopropylmethylnoroxymorphone Naltrexon Naltrexona Naltrexona [INN-Spanish] Naltrexone Naltrexone (USAN/INN) Naltrexone Hcl Naltrexone Hydrochloride Naltrexone [USAN:BAN:INN] Naltrexone [USAN:INN:BAN] Naltrexone [Usan:Ban:Inn] Naltrexonum Naltrexonum [INN-Latin] PDSP2_000847 PTI-555 Prestwick0_000116 Prestwick1_000116 Prestwick2_000116 Prestwick3_000116 ReVia Revia SMP1_000206 SPBio_002071 UM-792 UNII-5S6W795CQM Vivitrex Vivitrol Vivitrol (TN) naltrexone naltrexone (ReVia) |
| | 6 | | Heroin | approved, illicit | Phase 4 | 109 | 561-27-3 | 5462328 | (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester) 3,6-Diacetylmorphine 7,8-Dihydro-4,5-alpha-epoxy-17-methylmorphinan-3,6-alpha-diol diacetate Heroin | Heroin hydrochloride O,O'-diacetylmorphine Smack diacetylmorphine diamorphine morphine diacetate |
| | 7 | | Antipsychotic Agents | | Phase 4, Phase 1 | 2130 | | | | 8 | | Narcotics | | Phase 4, Phase 3 | 2709 | | | | 9 | | Peripheral Nervous System Agents | | Phase 4, Phase 1 | 18510 | | | | 10 | | Tranquilizing Agents | | Phase 4, Phase 1 | 3597 | | | | 11 | | Central Nervous System Depressants | | Phase 4, Phase 1 | 10016 | | | | 12 | | Psychotropic Drugs | | Phase 4, Phase 1 | 5501 | | | | 13 | | Quetiapine Fumarate | | Phase 4 | 403 | 111974-72-2 | | | 14 | | Narcotic Antagonists | | Phase 4 | 814 | | | | 15 | | | | Phase 3, Phase 2 | | | | | 16 | | Acamprosate | approved, investigational | Phase 2 | 38 | 77337-76-9 | 71158 | 3-(Acetylamino)propanesulphonic acid 3-Acetamido-1-propanesulfonic acid 3-acetamidopropane-1-sulfonic acid 77337-70-3 (mono-hydrochloride salt) 77337-71-4 (mono-potassium salt) 77337-72-5 (mono-lithium salt) 77337-73-6 (calcium[2:1] salt) 77337-74-7 (magnesium[2:1] salt) 77337-76-9 AC1L2FNA AC1Q1L6O AC1Q6X8K AOTA AR-1H6082 Acamprosate Acamprosate (INN) Acamprosate 6473 Acamprosate Calcium Acamprosate [INN:BAN] Acamprosato Acamprosato [INN-Spanish] | Acamprosatum Acamprosatum [INN-Latin] Aotal Aotal (TN) C5H11NO4S CHEBI:51041 CID71158 Campral D07058 DB00659 EINECS 278-667-4 HSDB 7358 LS-120940 N-Acetylhomotaurine N-acetyl homotaurine UNII-N4K14YGM3J acamprosate acamprosate (Campral) acamprostate calcium acetyl homotaurinate calcium acetylhomotaurinate calcium acetylhomotaurine sodium acetylhomotaurine |
| | 17 | | Acetylcysteine | approved | Phase 2 | 293 | 616-91-1 | 12035 | (2R)-2-acetylamino-3-Sulfanylpropanoic acid (R)-2-acetylamino-3-Mercaptopropanoic acid (R)-Mercapturic acid 2-Acetylamino-3-mercapto-propionate 2-Acetylamino-3-mercapto-propionic acid ACC Acetadote Acetilcisteina Acetylcysteine Acetylcysteinum Fluimicil Infantil Fluimucetin Fluimucil Flumucetin | Fluprowit L-Acetylcysteine L-alpha-acetamido-beta-Mercaptopropionic acid Lysox Mercapturic acid Mucolysin Mucomyst N-ACETYL-L-cysteine N-Acety-L-Cysteine N-Acetyl-3-mercaptoalanine N-Acetyl-L-(+)-cysteine N-Acetylcysteine N-acetylcysteine NAC Parvolex Sodium 2-acetamido-3-mercaptopropionate |
| | 18 | | Protective Agents | | Phase 2, Phase 1 | 5651 | | | | 19 | | Antioxidants | | Phase 2, Phase 1 | 2442 | | | | 20 | | Expectorants | | Phase 2 | 337 | | | | 21 | | N-monoacetylcystine | | Phase 2 | 293 | | | | 22 | | Respiratory System Agents | | Phase 2 | 3931 | | | | 23 | | Anti-Infective Agents | | Phase 2 | 17220 | | | | 24 | | Antiviral Agents | | Phase 2 | 8071 | | | | 25 | | glutamine | Nutraceutical | Phase 2 | 144 | | | | 26 | | Glutamic Acid | Nutraceutical | Phase 2 | 201 | | | | 27 | | Pramipexole | approved, investigational | Phase 1 | 137 | 104632-26-0 | 59868, 119570 | (-)-Pramipexole (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine (6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole (S)-N  6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine 104632-26-0 111GE001 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole 2-amino-6-propylaminotetrahydrobenzothiazole AC1L3P1T BIDD:GT0250 C10H17N3S CHEBI:8356 CHEMBL301265 CID119570 CPD000449298 D05575 DivK1c_006916 Furfuryl Acetate HMS2051A21 HMS2090C15 KBio1_001860 KBio2_002340 KBio2_004908 KBio2_007476 | KBioSS_002343 LS-40722 MLS000758250 MLS001423952 Mirapex MolPort-003-849-957 NCGC00167441-01 Pramipexol Pramipexol [Spanish] Pramipexole Pramipexole (USAN/INN) Pramipexole 2HCl Monohydrate Pramipexole Dihydrochloride Extended-Release Pramipexole [USAN:INN] Pramipexole hydrochloride Pramipexolum Pramipexolum [Latin] SAM001247006 SBB070477 SMR000449298 SND-919 SUD919CL2Y SpecPlus_000820 Spectrum5_001453 Spectrum_001838 U-98528E pramipexole | |
| | 28 | | Dopamine | approved | Phase 1 | 3084 | 62-31-7, 51-61-6 | 681 | (3H)-Dopamine .Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride .alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI) 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium 153C5321-5FEE-4B0B-8925-F388F0EEEBD1 2-(3,4-Dihydroxyphenyl)ethylamine 2-(3,4-dihydroxyphenyl)ethylamine 2-benzenediol 3,4-Dihydroxyphenethylamine 3,4-Dihydroxyphenethylamine hydrochloride 3,4-Dihydroxyphenylethylamine 3,4-dihydroxyphenethylamine 3-Hydroxtyramine 3-Hydroxytyramine 3-Hydroxytyramine Hydrobromide 3-Hydroxytyramine hydrochloride 4-(2-Aminoethyl)-1, 4-(2-Aminoethyl)-1,2-benzenediol 4-(2-Aminoethyl)-1,2-bezenediol 4-(2-Aminoethyl)-Pyrocatechol 4-(2-Aminoethyl)benzene-1,2-diol 4-(2-Aminoethyl)catechol 4-(2-Aminoethyl)pyrocatechol 4-(2-Aminoethyl)pyrocatechol hydrochloride 4-(2-aminoethyl)-pyrocatechol 50444-17-2 51-61-6 62-31-7 (HYDROCHLORIDE) AC1L19S5 AC1Q54AX AC1Q54AY AKOS003790978 ASL 279 BIDD:ER0506 BPBio1_001123 BSPBio_001932 Biomol-NT_000001 C03758 CHEBI:18243 CHEMBL59 CID681 D07870 DB00988 Deoxyepinephrine DivK1c_000780 Dopamin Dopamina Dopamina [INN-Spanish] Dopamine Dopamine (INN) Dopamine (USAN)(*hydrochloride*) Dopamine Hcl Dopamine Hydrochloride Dopamine [INN:BAN] Dopaminum Dopaminum [INN-Latin] Dopastat Dophamine Dynatra EINECS 200-110-0 HSDB 3068 Hydroxytyramin Hydroxytyramine IDI1_000780 IP 498 Intropin Intropin [*hydrochloride*] | KBio1_000780 KBio2_001492 KBio2_002388 KBio2_002484 KBio2_004060 KBio2_004956 KBio2_005052 KBio2_006628 KBio2_007524 KBio2_007620 KBio3_001152 KBio3_002867 KBio3_002962 KBioGR_001129 KBioGR_002388 KBioGR_002484 KBioSS_001492 KBioSS_002393 KBioSS_002491 KW-3-060 L-DOPAMINE L000232 LDP LS-159 Lopac-H-8502 Lopac0_000586 Medopa (TN) MolPort-001-641-000 NCGC00015519-01 NCGC00015519-08 NCGC00096050-01 NCGC00096050-02 NCGC00096050-03 NCGC00096050-04 NCGC00096050-05 NINDS_000780 NSC 173182 NSC169105 NSC173182 Oprea1_088821 Oxytyramine Pyrocatechol, 4-(2-aminoethyl)- (8CI) Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride Revimine Revivan SPBio_001205 SPECTRUM1505155 ST048774 STK301601 Spectrum2_001023 Spectrum3_000406 Spectrum4_000525 Spectrum5_000945 Spectrum_001012 UNII-VTD58H1Z2X UPCMLD0ENAT5885989:001 a-(3,4-Dihydroxyphenyl)-b-aminoethane alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane cMAP_000036 cMAP_000065 dopamine hydroxytyramine intropin m-Hydroxytyramine hydrochloride nchembio.105-comp9 nchembio.107-comp4 nchembio.284-comp1 nchembio.78-comp16 nchembio.89-comp3 nchembio705-8 nchembio801-comp8 |
| | 29 | | Prednisone | approved | Phase 1 | 1267 | 53-03-2 | 5865 | (1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione .delta. E .delta.(sup1)-Cortisone .delta.-Cortelan .delta.-Cortisone .delta.-Cortone .delta.-E .delta.1-Cortisone .delta.1-Dehydrocortisone .delta.sone 1,2-Dehydrocortisone 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione 1-Cortisone 1-Dehydrocortisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione 53-03-2 68-59-7 81552_FLUKA AC-11112 AC1L1LB2 AC1Q29EZ ACon0_000082 ACon1_000297 AI3-52939 Adasone Ancortone Apo-Prednisone Apo-prednisone BPBio1_000323 BRD-K85883481-001-04-2 BSPBio_000293 Betapar Bicortone Bio-0649 C07370 C21H26O5 CCRIS 2646 CHEBI:8382 CHEMBL635 CID5865 CPD001227202 Cartancyl Colisone Cortan Cortancyl Cortidelt Cotone DB00635 Dacorten Dacortin Decortancyl Decortin Decortisyl Dehydrocortisone Dekortin Delcortin Dellacort Dellacort A Delta Cortelan Delta E Delta E. Delta-Cortelan Delta-Dome Delta-cortelan Delta-cortisone Delta-cortone Delta-dome Deltacortene Deltacortisone Deltacortone Deltasone Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone Deltison Deltisona Deltisone Deltra Di-Adreson Diadreson EINECS 200-160-3 Econosone Encorton Encortone Enkortolon Enkorton Fernisone Fiasone HMS1568O15 HMS2090J13 HSDB 3168 Hostacortin In-Sone Incocortyl Juvason | Kortancyl LMST02030180 LS-1325 Liquid Pred Lisacort Lodotra MEGxm0_000443 MLS001061265 MLS001304073 MLS001335907 MLS001335908 MLS002154191 MLS002207083 Me-Korti Metacortandracin Meticorten Meticorten (Veterinary) Metrevet (Veterinary) MolPort-001-740-041 NCGC00090766-01 NCGC00090766-02 NCGC00090766-03 NCI-C04897 NCI60_000008 NSC 10023 NSC10023 Nisona Nizon Novoprednisone Nurison Orasone Origen Prednisone P1276 P6254_SIGMA PRD Panafcort Panasol Paracort Parmenison Pehacort Perrigo Prednisone Precort Predeltin Prednicen-M Prednicorm Prednicort Prednicot Prednidib Prednilonga Prednison Prednisona Prednisona [INN-Spanish] Prednisone Prednisone Intensol Prednisone [INN:BAN] Prednisonum Prednisonum [INN-Latin] Prednitone Prednizon Prednovister Presone Prestwick0_000077 Prestwick1_000077 Prestwick2_000077 Prestwick3_000077 Prestwick_405 Pronison Pronisone Rayos Rectodelt Retrocortine S1622_Selleck SAM002264641 SK-Prednisone SMR000718760 SMR001227202 SPBio_002214 Servisone Sone Sterapred Supercortil U 6020 UNII-VB0R961HZT Ultracorten Ultracortene WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ Winpred Wojtab ZINC03875357 Zenadrid Zenadrid (veterinary) Zenadrid [veterinary] delta cortelan delta(sup 1)-Cortisone delta(sup 1)-Dehydrocortisone delta-1-Cortisone delta-1-Dehydrocortisone delta-Cortisone delta-Cortone | |
| | 30 | | Dexamethasone | approved, investigational | Phase 1 | 1909 | 50-02-2 | 5743 | (3H)-Dexamethasone .delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol .gamma.corten 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone 1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone 1-Dehydro-16α-methyl-9α-fluorohydrocortisone 137098-19-2 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone 16-alpha-Methyl-9-alpha-fluoroprednisolone 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol 16alpha -Methyl-9alpha -fluoroprednisolone 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone 16alpha-Methyl-9alpha-fluoroprednisolone 16α-Methyl-9α-fluoro-1-dehydrocortisol 23495-06-9 31375_FLUKA 46165_FLUKA 46165_RIEDEL 50-02-2 8054-59-9 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione 9-Fluoro-16-methylprednisolone 9-alpha-Fluoro-16-alpha-methylprednisolone 9.alpha.-Fluoro-16.alpha.-methylprednisolone 906422-84-2 9A-FLUORO-16BETA-METHYLPREDNISOLONE 9alpha -Fluoro-16alpha -methylprednisolone 9alpha-Fluoro-16alpha-methylprednisolone 9alpha-fluoro-16alpha-methyl-Prednisolone 9α-Fluoro-16α-methylprednisolone AC-11056 AC1L1L1H AC1Q29DM AI3-50934 Adexone Aeroseb-D Aeroseb-Dex Aeroseb-dex Ak Dex Oph Otic Soln 0.1% Alcon Brand of Dexamethasone Anaflogistico Aphtasolon Aphthasolone Apo-dexamethasone Auxiron Azimycin (veterinary) Azium Azium (Veterinary) Azium (veterinary) BIDD:ER0494 BIDD:PXR0060 BRD-K38775274-001-02-3 BRD-K38775274-001-06-4 BSPBio_000995 Baycadron Bisu DS Bisu Ds C15643 C22H29FO5 CCRIS 7067 CHEBI:41879 CHEMBL384467 CID5743 CPD-10549 CPD001227192 Calonat Corson Corsone Cortisumman D00292 D003907 D1756_SIGMA D4902_SIGMA D6645_SIGMA D8893_SIGMA D9184_SIGMA DB01234 DEX DEXA DEXONE 0.5 DEXONE 0.75 DEXONE 1.5 DEXONE 4 DXM DXMS Decacort Decacortin Decaderm Decadron Decadron (TN) Decadron Tablets, Elixir Decadron, Dexamethasone Decadron-LA Decadron-La Decagel Decaject Decaject L.A. Decaject-L.A. Decalix Decameth Decasone Decaspray Dectancyl Dekacort Delta1-9alpha-Fluoro-16alpha-methylcortisol Deltafluorene Dergramin Deronil Desadrene Desametasone Desametasone [DCIT] Desametasone [Dcit] Desamethasone Desameton Deseronil Dex-Ide Dex-ide Dexa Dexa Mamallet Dexa mamallet Dexa-Cortidelt Dexa-Cortisyl Dexa-Mamallet Dexa-Scheroson Dexa-Sine Dexa-cortidelt Dexa-cortisyl Dexa-scheroson Dexa-sine Dexacen-4 Dexacidin Dexacort Dexacortal Dexacortin Dexadeltone Dexafarma Dexair Dexalona Dexaltin Dexametasona Dexametasona [INN-Spanish] Dexametasone Dexameth Dexamethansone | Dexamethasone Dexamethasone (JP15/USP/INN) Dexamethasone Acetate Dexamethasone Alcohol Dexamethasone Base Dexamethasone Intensol Dexamethasone Sodium Phosphate Dexamethasone [INN:BAN:JAN] Dexamethasone acetate Dexamethasone alcohol Dexamethasone base Dexamethasone intensol Dexamethasone sodium phosphate Dexamethasone-omega Dexamethasonum Dexamethasonum [INN-Latin] Dexamethazone Dexamethsone Dexamonozon Dexapolcort Dexapos Dexaprol Dexason Dexasone Dexasone 0.5mg Dexasone 0.75mg Dexasone 4mg Dexasporin Dexinolon Dexinoral Dexone Dexone 0.5 Dexone 0.75 Dexone 1.5 Dexone 4 Dexonium Dexpak Dextelan Dezone Dinormon Dxms ECR Brand of Dexamethasone EINECS 200-003-9 FT-0080377 Fluormethylprednisolone Fluormone Fluorocort Fortecortin Foy Brand of Dexamethasone Gammacorten HL-dex HMS1792A17 HMS1990A17 HMS2089N13 HSDB 3053 Hexadecadrol Hexadrol Hexadrol Elixir Hexadrol Tablets Hexadrol elixir Hl-Dex Hl-dex I06-1196 ICN Brand of Dexamethasone IontoDex Isopto-Dex Isopto-dex LS-7300 Lokalison F Lokalison f Loverine Luxazone MK 125 MLS001055412 MLS001332507 MLS001332508 Maxidex Maxidex Ont 0.1% Maxidex Sus 0.1% Maxitrol Mediamethasone Merck Brand of Dexamethasone Merz Brand 1 of Dexamethasone Merz Brand 2 of Dexamethasone Methylfluorprednisolone Mexidex Millicorten MolMap_000018 MolPort-003-846-433 Mymethasone NCGC00091019-01 NCGC00091019-02 NCGC00091019-03 NCGC00091019-04 NCGC00091019-05 NCI60_003067 NSC 34521 NSC34521 Naquasone (veterinary) Neomycin and polymyxin b sulfates and dexamethasone Neomycin and polymyxin b sulphates and dexamethasone OTO-104 Ocu-Trol Ocu-trol Oradexon Ozurdex PHL-dexamethasone PMS-dexamethasone Pet Derm III Pet Derm Iii Pet derm III Pet-Derm Iii Pms Dexamethasone Elixir 0.5mg/5ml Policort Posurdex Prednisolon F Prednisolon f Prednisolone F Prednisolone f Prodex S1322_Selleck SAM002548948 SGCUT00126 SK-Dexamethasone SK-dexamethasone SMP1_000092 SMR000857119 SMR001227192 ST50307091 Sandoz dexamethasone Sk-Dexamethasone Spectrum5_002019 Spoloven Sunia Sol D Sunia sol D Superprednol TL8003317 Tobradex Tobramycin and dexamethasone Tresaderm (veterinary) Turbinaire UNII-7S5I7G3JQL Visumetazone WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1 ZINC03875332 alpha -Fluoro-16-alpha -methylcortisol delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta1-9alpha-Fluoro-16alpha-methylcortisol dexamethasone nchembio809-comp2 to_000038 | |
| | 31 | | Docetaxel | approved, investigational, Approved May 1996 | Phase 1 | 1844 | 114977-28-5 | 148124, 9877265 | (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoate (2alpha,5beta,7beta,10beta,13alpha)-4-(acetyloxy)-13-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7,10-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate 01885_FLUKA 114977-28-5 4-(Acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate 4-(acetyloxy)-13alpha-({(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate AC-383 AC1L3WHJ ANX-514 BIND-014 C11231 CHEBI:4672 CHEMBL92 CID148124 D07866 DB01248 Docefrez Docetaxel Docetaxel (INN) Docetaxel anhydrous Docetaxel, Trihydrate EmDOC | HMS2089K08 InChI=1/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,5 MolPort-003-847-005 N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel N-Debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetylpaclitaxel N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol N-debenzoyl-N-Boc-10-deacetyl taxol NSC-628503 PSMA-targeted docetaxel nanoparticle RP-56976 SDP-014 TXL Taxotere Taxotere (TN) Taxotere(R) XRP-6976L docetaxel docetaxel 114977-28-5 nchembio.188-comp8 nchembio.2007.34-comp7 nchembio.573-comp11 nchembio853-comp8 | |
| | 32 | | Dopamine Agonists | | Phase 1 | 544 | | | | 33 | | Central Nervous System Stimulants | | Phase 1 | 1721 | | | | 34 | | Dopamine Antagonists | | Phase 1 | 927 | | | | 35 | | Dopamine Agents | | Phase 1 | 3084 | | | | 36 | | Antiparkinson Agents | | Phase 1 | 1312 | | | | 37 | | Neurotransmitter Agents | | Phase 1 | 14795 | | | | 38 | | sultopride | | Phase 1 | 46 | | | | 39 | | HIV Protease Inhibitors | | Phase 1 | 4558 | | | | 40 | | Hormone Antagonists | | Phase 1 | 10002 | | | | 41 | | Hormones | | Phase 1 | 11748 | | | | 42 | | Hormones, Hormone Substitutes, and Hormone Antagonists | | Phase 1 | 9988 | | | | 43 | | Protease Inhibitors | | Phase 1 | 4558 | | | | 44 | | glucocorticoids | | Phase 1 | 3896 | | | | 45 | | Anti-Inflammatory Agents | | Phase 1 | 8478 | | | | 46 | | Gastrointestinal Agents | | Phase 1 | 6401 | | | | 47 | | Antineoplastic Agents, Hormonal | | Phase 1 | 4256 | | | | 48 | | Antiemetics | | Phase 1 | 3213 | | | | 49 | | BB 1101 | | Phase 1 | 1909 | | | | 50 | | Dexamethasone acetate | | Phase 1 | 1909 | 1177-87-3 | |
Interventional clinical trials: (show all 14)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope | Recruiting | NCT01357967 | Phase 4 | | 2 | Biomarkers of Injectable Extended Release Naltrexone Treatment | Enrolling by invitation | NCT02324725 | Phase 4 | | 3 | Making Alcoholics Anonymous Easier | Completed | NCT01382316 | Phase 3 | | 4 | Acamprosate to Reduce Symptoms of Alcohol Withdrawal | Completed | NCT00106106 | Phase 2 | | 5 | N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD | Terminated | NCT00539188 | Phase 2 | | 6 | Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors | Completed | NCT00471588 | Phase 1 | | 7 | Reducing Dexamethasone Around Docetaxel Infusion | Recruiting | NCT02776436 | Phase 1 | | 8 | Epidemiological Studies of Eating Disorders in Gifted Dance Students (2nd Year). | Completed | NCT00173160 | | | 9 | Reward Processing in Cocaine Addiction | Completed | NCT01036074 | | | 10 | Narrative Exposure Therapy in Women With Borderline Personality Disorder and Posttraumatic Stress Disorder | Recruiting | NCT02517723 | | | 11 | Differential Efficacy of Supportive and Interpretative Psychodynamic Techniques for Dependent and Self-critical Depressive Patients | Recruiting | NCT01640483 | | | 12 | Characterization Imaging Instruments in Alcoholics and Non-Alcoholics | Recruiting | NCT02108080 | | | 13 | Assessment of Persistent Cognitive Impairment After Cure of Cushing's Disease | Not yet recruiting | NCT02603653 | | | 14 | Endogenous Opioid Mechanisms for Rejection Sensitivity | Not yet recruiting | NCT02189785 | |
|
